PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
CD22 1,591 Target Target Epidermal Growth Factor Receptor 24,772 1 0.00 -1.00 0.00 0.52
Varicose Veins 5,072 Disease Target CEA 17,022 1 0.00 -1.00 0.00 0.50
Abilify (Aripiprazole)- FDA 71 Drug Target Multidrug Resistance Protein 1 495 1 0.01 -0.99 0.01 0.70
Diabetic Nephropathy 12,496 Disease Target BDNF 11,163 1 0.00 -1.00 0.00 0.49
Abilify (Aripiprazole)- FDA 71 Drug Target D(2) Dopamine Receptor 1,559 1 0.00 -0.99 0.01 0.66
Diabetic Nephropathy 12,496 Disease Target CD34 24,598 5 0.00 -1.00 0.00 0.51
Diabetic Nephropathy 12,496 Disease Target CA 50 1,293 3 0.00 -1.00 0.00 0.57
Diabetic Nephropathy 12,496 Disease Target Elastase 13,875 6 0.00 -1.00 0.00 0.54
Diabetic Nephropathy 12,496 Disease Target BMP-2 3,889 5 0.00 -1.00 0.00 0.56
Abilify (Aripiprazole)- FDA 71 Drug Target CER 2,421 1 0.00 -0.99 0.01 0.65
Diabetic Nephropathy 12,496 Disease Target CXCL10 2,386 5 0.00 -1.00 0.00 0.58
Diabetic Nephropathy 12,496 Disease Target Activin A 2,048 2 0.00 -1.00 0.00 0.55
Diabetic Nephropathy 12,496 Disease Target Equilibrative Nucleoside Transporter 1 211 1 0.00 -1.00 0.00 0.58
Diabetic Nephropathy 12,496 Disease Target Galectin-1 1,131 1 0.00 -1.00 0.00 0.55
Cervical Cancer 28,286 Disease Target Cytokeratin 18 1,108 2 0.00 -1.00 0.00 0.54
Diabetic Nephropathy 12,496 Disease Target CCL21 808 1 0.00 -1.00 0.00 0.55
Diabetic Nephropathy 12,496 Disease Target CYR61 539 3 0.00 -1.00 0.01 0.59
Cervical Cancer 28,286 Disease Target Multidrug Resistance Protein 1 495 1 0.00 -1.00 0.00 0.54
Diabetic Nephropathy 12,496 Disease Target Cytokeratin 18 1,108 3 0.00 -1.00 0.00 0.58
Diabetic Nephropathy 12,496 Disease Target Hypoxia-Inducible Factor 1-Alpha 923 3 0.00 -1.00 0.00 0.58